Inflammation

Researchers have identified a blood profile that could help identify COVID-19 patients at greatest risk of deterioration and direct them towards trials of specific treatments that could modify their immune systems' responses

The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients

Partnership combines molecular patient data, AI-based methods to identify novel targets and pathways

Cellectricon offers fully validated in vitro disease models including human iPSC-derived neuronal cultures, cell lines, and native neuronal cultures

The genetic mutation shares a link with the JAK2 pathway, an important target of multiple immunotherapies

Mutations in the RIPK1 gene responsible for CRIA syndrome

Researchers outlined immune dysfunction in mice that leads to more severe respiratory infections in those with diabetes

Analysis of DNA from nearly half million people should speed efforts to develop gout screening tests, treatments

In a recent pilot, cross sectional study, both systemic and airway inflammatory markers were compared in patients with sickle cell disease with and without asthma or obstructive airway symptoms

Findings might help predict who will react poorly to certain therapies